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Diminished Fraction of Blockable ATP-Sensitive
K+ Channels in Islets Transplanted Into Diabetic
Mice
Bernat Soria, Franz Martin, Etelvina Andreu, Juan Vicente Sanchez-Andres, Victor Nacher,
and Eduard Montana
The reasons for the poor outcome of islet transplanta-
tion in diabetic patients are not well known; a better
understanding of the pathophysiology of transplanted
islets is needed. To study the mechanism coupling sec-
retagogue stimuli with insulin release in transplanted
islets, we determined the effects of glucose, tolbu-
tamide, and carbamylcholine on the (5-cell membrane
potential and cytosolic calcium concentrations
([Ca2+]j) of islets syngeneically transplanted into nor-
mal and streptozocin-induced diabetic mice. In both
groups, normoglycemia was maintained after trans-
plantation. Islets transplanted into normal recipients
showed similar changes in P-cell membrane potential
and [Ca2+]j oscillations to those in control islets. In
contrast, when islets were transplanted into diabetic
mice, bursts of electrical activity were triggered at
lower glucose concentrations (5.6 mmol/1) than in con-
trol islets (11 mmol/1), and maximal electrical activity
was achieved at lower glucose concentrations (11
mmol/1) than in control islets (22 mmol/1). When mem-
brane potential was plotted as a function of glucose
concentration, the dose-response curve was shifted to
the left. Compared with control islets, glucose-
induced [Ca2+]j oscillations were broader in duration
(22.3 ± 0.6 s vs. 118.1 ± 12.6 s; P < 0.01) and higher in
amplitude (135 ± 36 nmol/1 vs. 352 ± 36 nmol/1; P <
0.01). Glucose supersensitivity was attributed to a
resting decrease in the fraction of blockable ATP-sen-
sitive K+ (K+ATP) channels in transplanted islets that
maintained normoglycemia with a limited P-cell mass.
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The efficacy of islet transplantation in restoringnormoglycemia in diabetic rats was firstdemonstrated 20 years ago (1), but the firstsuccessful transplants of islet cells in diabetic
patients were only recently reported (2-4). Up to 31
December 1994, a total of 243 adult islet allotransplants
had been reported in type I diabetic patients (5); however,
insulin independence was achieved in only 19 recipients,
and, even in these patients, it had limited duration (6).
Why transplanted islets survive only a limited time in dia-
betic patients is not well understood. Early and late fail-
ures of islet autotransplants in animal models suggest that
nonimmunological factors could play a role in these poor
outcomes (7). The physiological basis of these failures is
unknown; thus a better understanding of the pathophysi-
ology of transplanted islets is needed to overcome the
problems that currently hamper islet transplantation.
It is well established that stimulatory glucose concen-
trations (> 7 mmol/1 in mouse (3-cells) induce a decrease
in K+ conductance (8,9) because of the closure of K+ATP
channels (10,11). The subsequent depolarization causes
bursts of electrical activity (12), [Ca2+]j oscillations
(13,14), and insulin release (15-17). In summary, current
models accept that K+ATP conductance modulates the
dose-response curve to glucose in ionic events (18,19).
So far it is not known to what extent features of this
model can be applied to transplanted islets. Thus, in our
study we investigated the mechanism coupling secreta-
gogue stimuli with insulin release in islet cells syngene-
ically transplanted under the kidney capsule of normal
and streptozocin-induced diabetic mice.
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RESEARCH DESIGN AND METHODS
Animals and treatments. Male inbred C57B1/6 mice (B & K Universal,
U.K.), age 8-12 weeks, were used as donors and recipients of the transplan-
tation. Animals were made diabetic by a single intraperitoneal injection of
streptozocin (STZ) (Sigma, St. Louis, MO), 160 mg/kg of body weight, freshly
dissolved in citrate buffer (pH 4.5). Before transplantation, diabetes was
confirmed by the presence of blood glucose levels higher than 20 mmol/1,
weight loss, and polyuria. Blood glucose was obtained from the snipped tail
and measured between 9:00 A.M. and 11:00 A.M., in nonfasting conditions,
with a portable glucose meter (Accutrend GC, Boehringer Mannheim,
Mannheim, Germany).
Three groups of mice were studied: 1) STZ-Tx group (n = 9): STZ-induced
diabetic mice transplanted with 400 islets; 2) Tx group (n = 4): normo-
glycemic non-STZ-injected mice transplanted with 150 islets; and 3) control
group (n - 12): normoglycemic non-STZ-injected and nontransplanted mice.
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Membrane potential and [Ca2+]; oscillations were measured in the trans-
planted islets of 3 animals of the STZ-Tx group and 4 animals of the Tx
group; they were also measured in the native pancreatic islets of the Tx-
group mice and in 6 mice of the control group, p-cell mass was determined
in the grafts of 6 mice of the STZ-Tx group and in the pancreases of 6 mice
of the control group not used for membrane potential and [Ca2+]j oscillation
measurements.
Islet isolation and transplantation. Islets were isolated as previously
described (20). Briefly, after pancreas digestion with collagenase (Collagen-
ase P, Boehringer Mannheim Biochemicals, Mannheim, Germany) in a sta-
tionary bath at 37°C, islets were separated on a density gradient
(Hystopaque-1077, Sigma Immunochemicals, St. Louis, MO), and hand-
picked under a stereomicroscope. The islets were placed into 200-ml pipette
tips, allowed to sediment, and then gently transferred to a polyethylene tub-
ing PE-50 (Becton Dickinson, Sparks, MD) with the help of a 1-ml Hamilton
syringe (Hamilton, Reno, NE). The tubing was folded and centrifuged for 1
min at 400$ to pellet the islets; after centrifugation, the pipette tip was again
connected to the Hamilton syringe. With the mouse under light ether anes-
thesia, the kidney was exposed through a lumbar incision. A capsulotomy
was performed in the lower pole of the kidney and the tip of the tubing
advanced under the capsule to the upper pole where islets were injected
using the Hamilton syringe.
Grafts and pancreas removal. Grafts were harvested 4 weeks after trans-
plantation. With the mouse under light ether anesthesia, the kidney was
exposed and the graft identified as a white patch. The kidney capsule sur-
rounding the graft was incised and removed with the graft (20). Immediately
after graft removal, either individual well-defined islets were microdissected
from the graft to measure membrane potential and [Ca2+]j, or the whole graft
was weighed and fixed in Bouin's solution to measure p-cell mass. For pan-
creas removal, a midlaparotomy was performed and the pancreas was
exposed, the animal was killed, and the pancreas was dissected from sur-
rounding tissues, excised, blotted, weighed, and fixed in Bouin's solution.
Electrophysiology. The p-cell membrane potential was recorded as previ-
ously described (21). Once isolated, islets were fixed with micropins to the
bottom of a 50-ul chamber and perifused at a rate of 0.8 ml/min with fresh
modified Krebs medium and constantly gassed with a mixture of O2 (95%) and
CO2 (5%) for a final pH of 7.4. Different glucose concentrations (5.6, 11, and
22 mmol/1) were added to the superfusion medium. The test agents reached
the chamber with a delay of 3 s (these delays have been corrected in the fig-
ures). Bath temperature was maintained at 36 ± 1°C by heating a thermostat-
controlled stainless steel ring. The temperature of the chamber was continu-
ously monitored with a microthermistor. Recordings were made with an
Axoclamp 2B amplifier (Axon Instruments, Foster City, CA). Data acquisition
was performed with Axotape version 2.0 (Axon Instruments) and data analy-
sis with MicroCal Origin version 3.7 (MicroCal Software, Northampton, MA).
Cytosolic Ca2+ measurement
Indo-1 loading. Once microdissected from the graft or isolated from the
pancreas, the islets were incubated for 1 h at 37°C in modified Krebs
medium supplemented with 5 mmol/1 glucose and 3% bovine serum albumin
(BSA). The medium was continuously bubbled with a mixture of O2 (95%)
and CO2 (5%) for a final pH of 7.4. Isolated islets were loaded as previously
described (13). Islets were loaded with Indo-1 (Molecular Probes, Eugene,
OR) by incubation for 1 h at room temperature in the described medium
with 2 umol/1 of the acetoxymethyl derivative (AM) (Sigma Immunochemi-
cal). Indo-1 AM was added as a concentration stock solution in dimethyl
sulfoxide (DMSO) (Sigma Immunochemical; final DMSO concentration 0.3%
vol/vol). To facilitate the solubilization of Indo-1 AM in physiological media,
the mixture also contained 10% (wt/wt) of the nonionic surfactant polyol
pluronic F127 (Molecular Probes, Junction City, OR). After loading, islets
were incubated with a modified Krebs medium supplemented with 1% BSA.
The Krebs medium was kept at 37°C and constantly gassed with a mixture
of O2 (95%) and CO2 (5%) for a final pH of 7.4.
Superfusion of islets. Each islet was then transferred to an open chamber
(vol = 300 pi) mounted on the stage of an epifluorescence Nikon-Diaphot
inverted microscope (Nikon, Tokyo, Japan). Islets of similar, medium size
(100-200 um diameter) were used for all experiments. Individual islets were
left to settle down in the chamber for 1-2 min in the absence of perfusion.
Islets usually remained attached to the glass bottom of the chamber during
a perfusion experiment. Islets were superfused at a rate of 0.5 ml/min with
fresh modified Krebs medium supplemented with 1% BSA and constantly
gassed with a mixture of O2 (95%) and CO2 (5%) for a final pH of 7.4. Glucose
at different concentrations (3 and 11 mmol/1), 50 umol/1 tolbutamide, and 10
umol/1 carbamylcholine were added to the superfusion medium. The test
agents reached the chamber with a delay of 15 s (these delays have been cor-
rected in the figures). Bath temperature was maintained at 36 ± 1°C by heat-
ing a thermostat-controlled stainless steel ring. The temperature of the
chamber was continuously monitored with a microthermistor.
Measurements of cytosolic Ca2*. [Ca2+]j was monitored as previously
described (13) by measuring the fluorescence emitted by Indo-1. Indo-1 was
excited at 350 ± 5 nm by means of a 100-W mercury lamp. The level of ultra-
violet excitation light compatible with a good signal-to-ratio noise was
adjusted by placing neutral density filters in the light pathway to reduce
photobleaching and photodamage of the preparation. The emitted fluores-
cence was split into two beams with a dichroic mirror (450 nm), filtered
respectively at 410 ± 5 and 480 ± 5 nm, and detected by two photomultipli-
ers (Thorn EMI 9924B, Middlesex, England). An increase in [Ca2+]; produces
a rise in Indo-1 fluorescence at 410 nm; conversely, a fluorescence decrease
is observed at 480 nm (22). The fluorescence ratio (F410/F4SO) was determined
on-line and filtered at 10 kHz. Autofluorescence levels were measured from
control islets and found to be less than 15% of the total fluorescence.
(i-cell mass measurement. After removal, grafts and pancreases were
fixed in Bouin's solution and processed for paraffin embedding. Their
weights were determined on a Mettler A240 balance (Mettler Instrument,
Hightstown, NJ), reading to 0.01 mg, as previously described (20). Two-um
sections of grafts and pancreases were stained for the endocrine non-p-cells
of the islets with immunoperoxidase. Immunostaining used a cocktail of
antibodies (Dako, Carpinteria, CA): rabbit anti-porcine glucagon (final dilu-
tion 1:1000), rabbit anti-human somatostatin (final dilution 1:1000), and rab-
bit anti-human pancreatic polypeptide (final dilution 1:500). A swine anti-
rabbit IgG was used as a secondary antibody, p-cell mass was measured by
point counting morphometry (20). Each section was covered systematically
using a 48-point grid to obtain the number of intercepts over p-cells,
endocrine non-P-cells, and other tissue. The P-cell relative volume was cal-
culated by dividing the intercepts over p-cells by intercepts over total tissue,
then the P-cell mass was estimated by multiplying p-cell relative volume by
graft weight. The endocrine non-p-cell mass (a, 8, and PP cells) was deter-
mined in the same way.
Statistical analysis. Electrophysiological results (Fig. IB and 1(7) were
expressed as means and as standard error of the mean (X ± SE). For com-
parisons between two groups, the unpaired Welch's (test (two tailed) was
used. The remaining results were expressed as means and standard error of
the mean (X ± SE). For comparisons between two groups, the unpaired, two-
tailed Student's (test) was used. P < 0.05 was considered significant.
RESULTS
Normoglycemia was achieved in all STZ-Tx group mice 1
week after transplantation (6.6 ± 0.9 mmol/1) and was
maintained until graft harvesting (Table 1). As expected
(20), no changes in blood glucose were detected after
islet transplantation into normal nondiabetic recipients.
Electrophysiology and cytosolic Ca2+ measurement.
The glucose-induced electrical activity in p-cells from
control islets and from islets transplanted into STZ-Tx
group mice is summarized in Fig. 1. In STZ-Tx group, P-
cells (7 p-cells from 7 islets of 3 mice) showed an
increased glucose sensitivity compared with p-cells from
the pancreas of control group (9 P-cells from 9 islets of 6
mice) (Fig. LA). Transplanted p-cells in the STZ-Tx group
showed oscillatory electrical activity in response to
lower glucose concentrations (5.6 mmol/1) than in the
control group (11 mmol/1). Furthermore, the pattern of
response elicited in p-cells from the control group with
maximal glucose concentrations (22 mmol/1) was
achieved in transplanted P-cells from the STZ-Tx group
with 11 mmol/1 glucose. When the parameters studied—
membrane potential and fraction of time in active
phase—were plotted as a function of glucose concentra-
tion, the dose-response curve in transplanted p-cells
from the STZ-Tx group was found to be shifted left com-
pared with p-cells from the control group (Fig. IB and
1C). In contrast, no differences were found in the electri-
cal activity of p-cells from the control group, trans-
planted P-cells from the Tx group (6 p-cells from 6 islets
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Data are means ± SE. *P < 0.05 when compared with control group.
of 4 mice), and (3-cells from pancreases of the Tx group
(6 (3-cells from 6 islets of 4 mice; data not shown).
[Ca2+]j responses to glucose and tolbutamide are
shown in Fig. 2. Glucose-induced [Ca2+]j oscillations were
broader in duration and higher in amplitude (118.1 ± 12.6
s, P < 0.001; 352 ± 36 nmol/1, P < 0.001; 9 islets from 3
mice) in transplanted islets from the STZ-Tx group com-
pared with islets from the control group (22.3 ± 0.6 s and
135 ± 36 nmol/1; 10 islets from 6 mice) and with trans-
planted islets from the Tx group (24.0 ± 0.9 s and 121 ± 22
nmol/1; 6 islets from 4 mice) (Fig. 2A). The duration and
amplitude of glucose-induced oscillations were similar in
islets from the control group, islets transplanted into the
Tx group, and native pancreatic islets from the Tx-group
(7 islets, from 4 mice; data not shown).
Tolbutamide, an oral antidiabetic agent that specifi-
cally blocks K+ATP channels (23), potentiated the glucose
(11 mmol/1) effect on [Ca2+]j, increasing its cytosolic lev-
els in islets from the control group (11 mmol/1 glucose:
207 ± 14 nmol/1; 11 mmol/1 glucose plus 50 umol/1 tolbu-
tamide: 276 ± 21 nmol/1, P < 0.01; 6 islets from 6 mice)
and in islets transplanted in the Tx group (11 mmol/1 glu-
cose: 178 ± 25 nmol/1; 11 mmol/1 glucose plus 50 umol/1
tolbutamide: 285 ± 13 nmol/1, P < 0.01; 7 islets from 4
mice) (Fig. 2). Similar results were observed in islets iso-
lated from the pancreases of the Tx group (5 islets from
4 mice; data not shown). In contrast, in islets trans-
planted into the STZ-Tx group, the addition of 50 umol/1
tolbutamide to 11 mmol/1 glucose did not modify the
already increased amplitude of [Ca2+]j oscillations (11
mmol/1 glucose: 293 ± 14 nmol/1; 11 mmol/1 glucose plus
50 umol/1 tolbutamide: 309 ± 45 nmol/1, P = NS; 5 islets
from 3 mice) (Fig. 2E).
In response to carbamylcholine, a muscarinic receptor
agonist, changes in membrane potential (data not shown)
and in [Ca2+]4 (Fig. 3) were similar in islets from the con-
trol group (7 islets from 6 mice), in islets transplanted
into the Tx group (4 islets, from 4 mice), in native pan-
creatic islets from the Tx group (5 islets from 4 mice;
data not shown), and in islets transplanted into the STZ-
Tx group (6 islets from 3 mice).
P-cell mass. f3-cell mass was determined in normal pan-
creases of 6 control group mice and in 6 grafts trans-
planted into the STZ-Tx group mice. The (3-cell mass in
the 400-islet grafts (0.60 ± 0.09 mg) was significantly
lower than the P-cell mass in the pancreases of control
mice (1.09 ± 0.14 mg; P < 0.01). The endocrine non-p cell
mass (a, 8, and PP cells) was also lower in the grafts of
the STZ-Tx group (0.05 ± 0.01 mg) compared with pan-
creases of control mice (0.26 ± 0.05 mg; P < 0.001).
DISCUSSION
We studied the mechanism coupling secretagogue stimuli
with insulin release in islets transplanted into STZ-
induced diabetic mice and normal mice. When islets were


















































FIG. 1. Glucose-induced electrical activity in
transplanted islets. A: representative examples of
the effects of different glucose concentrations (0,
5.6, 11, and 22 mmol/1) on intracellularly recorded
membrane potential of a pancreatic p-cell in the
intact islet. Groups are described in Table 1. In
the STZ-Tx and control groups, the same islet was
perifused with the different glucose concentra-
tions. B: fraction of time in the active phase in
control (O) and STZ-Tx islet p-cells ( • ) . C: mem-
brane potential as function of glucose concentra-
tion, control group (O), STZ-Tx group ( • ) . Values
are expressed as means and standard error of the
mean (X ± SE). *P < 0.05 when compared with
control group.
1757
GLUCOSE SUPERSENSITIVITY IN TRANSPLANTED ISLETS
FIG. 2. Glucose- and tolbutamide-induced [Ca2+],
changes in transplanted islets. A: representative
examples of the effect of 11 mmol/1 glucose on
[Ca2+],. Islets were perifused with 3 mmol/1 glucose
before the addition of 11 mmol/1 glucose. 11
mmol/1 glucose was added during the time indi-
cated by the bars. B: representative examples of
the effect of 50 umol/1 tolbutamide in the presence
of 11 mM glucose on [Ca2+],. 50 umol/1 tolbutamide
was added during the time indicated by the bars.
Upper records show the control group, middle















































was restored after transplantation, electrical activity was
elicited in transplanted P-cells at lower glucose concen-
trations than in control islets from the pancreases of nor-
mal mice. Furthermore, in islets transplanted into STZ-Tx
diabetic mice [Ca2+]j, oscillations in response to glucose
had broader duration and higher amplitude than in con-
trol islets. Therefore, islets that restored normoglycemia
after transplantation into diabetic mice showed
increased sensitivity to glucose. In contrast, islets trans-
planted into normal nondiabetic mice had glucose sensi-
tivity similar to that of control islets.
Glucose-induced electrical activity in islets trans-
planted into STZ-induced diabetic mice was increased,
and the dose-response curve was left-shifted. When islets
transplanted into STZ-Tx mice were perifused with 5.6
mmol/1 glucose, a concentration too low to elicit activity
in control islets, they showed oscillatory electrical activ-
ity that was similar to that of control islets perifused with
11.1 mmol/1 glucose. Furthermore, maximal electrical
activity was achieved in STZ-Tx islets perifused with 11.1
mmol/1 glucose, whereas in control islets 22.2 mmol/1 glu-
cose was required for maximal electrical activity. [Ca2+]j
oscillations in response to glucose in islets transplanted
into STZ-Tx diabetic recipients also showed an increased
glucose sensitivity with broader duration and higher
amplitude of oscillations than control islets.
Denervation has been shown to cause supersensitivity
in other excitable cells (24). Islets are denervated when
transplanted, and initial islet reservation is detected 2
months after transplantation under the kidney capsule,
although it is not clearly established until 3-4 months
later (25). To determine whether glucose supersensitivity
was caused by denervation of transplanted islets, we
studied the effect of carbamylcholine on islet membrane
potential and cytosolic calcium. The response to car-
bamylcholine was similar in transplanted and in normal
pancreatic islets, indicating that muscarinic receptors
were present and operative 1 month after transplanta-
tion, and suggesting that they were not involved in glu-
cose increased sensitivity in transplanted islets.
To ascertain whether increased glucose-sensitivity was
common in all transplanted islets or related to the func-
tion of transplanted islets into diabetic recipients, we
compared the electrical activity and the [Ca2+]; oscilla-
tions in response to glucose in islets transplanted into
diabetic mice of the STZ-Tx group with the same param-
eters in islets transplanted into normal mice of the Tx-
group. As expected (21), transplantation did not modify
blood glucose values in the Tx-group. The electrical
activity and [Ca2+]j oscillations in the islets transplanted
into normal recipients were similar to those in control
islets, indicating that the mechanism coupling secreta-
gogue stimuli with insulin release and the glucose sensi-
tivity were normal in the Tx-group transplanted islets.
Therefore, transplantation by itself was not the cause of
the increased glucose sensitivity in the STZ-Tx group
islets, which was probably related to the function of
transplanted islets in the maintenance of normoglycemia
in the diabetic recipients.
The [Ca2+]j oscillations elicited by glucose in islets
transplanted into the STZ-Tx group strongly resembled
the slow oscillations induced by amino acids in mouse
islets (26). In this model, it was suggested that the amino
acid-induced closure of K+ATP channels that remained
opened after glucose stimulation accounted for the
appearance of these slow oscillations. It is known that
tolbutamide mimics the changes in electrical activity
induced by an increase in glucose concentration (19),
suggesting that closure of K+ATP channels that remain
open after glucose stimulation underlies the effects of
tolbutamide on electrical activity and [Ca2+];. To deter-
mine whether increased glucose sensitivity in STZ-Tx
group islets was mediated by a reduction in the fraction
of closable K+ATP channels, islets were perifused with
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FIG. 3. Carbamylcholine-induced [Ca2+], changes in transplanted
islets. In all the experiments, the islets were perifused with 3
mmol/l glucose. 10 umol/1 carbamylcholine was added during the
time indicated by the bars. Upper record shows the control group,
middle record the Tx-group, and lower record the STZ-Tx group.
tolbutamide. In islets transplanted in the Tx group and in
control islets, the addition of tolbutamide (50 umol/1) to
glucose induced the closure of additional K+ATP channels
and increased the [Ca2+]j to a sustained plateau that was
similar to the peak of the glucose-induced slow [Ca2+]j
oscillation in the STZ-Tx group. In contrast, addition of
tolbutamide did not modify [Ca2+]j oscillations in the STZ-
Tx group, suggesting that the number of closable K+ATP
channels was reduced in this group. The results indicated
that the fraction of blockable K+ATP channels was dimin-
ished in islets that restored and maintained normo-
glycemia after transplantation into diabetic mice and
accounted for the increased sensitivity to glucose.
Hyperglycemia is known to shift the glucose concen-
tration-insulin secretion curve to the left (27,28). In our
study, nonfasting normoglycemia was restored 1 week
after transplantation into STZ-Tx mice and maintained
until graft harvesting 3 weeks later, excluding hyper-
glycemia as the cause of glucose supersensitivity in
transplanted islets. Recently, increased (3-cell sensitivity
to glucose has been described in the presence of normo-
glycemia in spontaneously hypertensive rats (29) and
after partial pancreatectomy (30). A common character-
istic of these two models is the increased workload
placed on (3-cells that maintained normoglycemia despite
absolute or relative reductions in (3-cell mass. After a 60%
reduction in (3-cell mass, the islets in the pancreas
remainder had to meet an increased metabolic demand to
maintain normoglycemia (30). Spontaneously hyperten-
sive rats are insulin resistant, but do not experience the
compensatory increase in (3-cell mass found in other
insulin-resistant conditions (31,32), and therefore main-
tain normoglycemia with an inappropriately normal (3-
cell mass. To determine whether a similar situation was
present in our transplantation model, we measured the (3-
cell mass in the grafts of the STZ-Tx group and in the pan-
creases of control mice. The transplanted 3-cell mass
that maintained normoglycemia in the STZ-Tx group was
45% lower than the (3-cell mass in the pancreases of age-
matched control mice, indicating that an increased meta-
bolic demand was placed on transplanted p-cells.
Because there is a positive correlation between the rela-
tive length of the depolarized phase and the amount of
insulin secreted by (3-cells (33), we suggest that the left-
shifted glucose-induced electrical activity curve in trans-
planted islets was an adaptive response that increased
insulin secretion and maintained normoglycemia in the
presence of a reduced (3-cell mass.
In summary, the mechanism coupling secretagogue
stimuli with insulin secretion was preserved in trans-
planted islets. When islet transplantation restored nor-
moglycemia in the diabetic recipients, we found an
increased sensitivity to glucose in transplanted islets.
The increased sensitivity was caused by a reduction in
the fraction of closable K+ATP channels that we suggest
was an adaptive response of transplanted (3-cells that
maintained normoglycemia with a limited (3-cell mass.
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